发明申请
- 专利标题： TYPE I DIABETES THERAPY
-
申请号： US16637304申请日： 2018-08-07
-
公开(公告)号： US20200345815A1公开(公告)日： 2020-11-05
- 发明人: Helen E. Thomas , Thomas W. H. Kay , Balasubramanian Krishnamurthy , Gaurang Jhala
- 申请人： St. Vincent's Institute of Medical Research
- 申请人地址： AU Fitzroy
- 专利权人： St. Vincent's Institute of Medical Research
- 当前专利权人： St. Vincent's Institute of Medical Research
- 当前专利权人地址： AU Fitzroy
- 优先权： com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@790efac
- 国际申请： PCT/AU2018/050823 WO 20180807
- 主分类号： A61K38/28
- IPC分类号： A61K38/28 ; A61K38/46 ; A61K38/51 ; A61K38/17 ; A61K31/519 ; A61K31/541 ; A61K31/5355 ; A61K31/553 ; A61K31/529 ; A61K31/4985 ; A61K31/437 ; A61P3/10
摘要：
The present invention relates to novel methods and therapies for treating, preventing or delaying the onset of type 1 diabetes. In one aspect, the invention provides a method of preventing, delaying the onset of, or delaying the progression of, type 1 diabetes (T1D) in an individual, the method comprising providing in the individual an anti-inflammatory compound; and a pancreatic autoantigen or a derivative or variant thereof; thereby preventing, delaying the onset of, or delaying the progression of, T1D in the individual.
公开/授权文献
- US11806386B2 Type I diabetes therapy 公开/授权日：2023-11-07
信息查询
IPC分类:
